• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, October 13, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

PCORI offers up to $452 million through new health research funding opportunities on high-priority topics 

Bioengineer by Bioengineer
May 2, 2023
in Health
Reading Time: 4 mins read
0
Patient-Centered Outcomes Research institute
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

 WASHINGTON, D.C. – The Patient-Centered Outcomes Research Institute (PCORI) today began inviting proposals for new studies and implementation projects through nine funding opportunities. These PCORI Funding Announcements (PFAs) include four offering up to $452 million for comparative clinical effectiveness research (CER) studies comparing health care approaches to help patients and their caregivers make better-informed health choices given their particular circumstances. Additional PFAs offer funding for a range of projects that support and advance patient-centered CER and use of PCORI-funded research results.  

Patient-Centered Outcomes Research institute

Credit: Patient-Centered Outcomes Research Institute

 WASHINGTON, D.C. – The Patient-Centered Outcomes Research Institute (PCORI) today began inviting proposals for new studies and implementation projects through nine funding opportunities. These PCORI Funding Announcements (PFAs) include four offering up to $452 million for comparative clinical effectiveness research (CER) studies comparing health care approaches to help patients and their caregivers make better-informed health choices given their particular circumstances. Additional PFAs offer funding for a range of projects that support and advance patient-centered CER and use of PCORI-funded research results.  

 

“With these latest funding opportunities, PCORI proudly continues to fulfill its role as a leading funder of patient-centered, comparative clinical effectiveness research,” said Nakela L. Cook, M.D., MPH, PCORI’s executive director. “The research funded through these opportunities will generate sound evidence to help patients, their clinicians and caregivers understand their care options and become more empowered decision makers across a range of health conditions. Projects funded through these opportunities also will generate data and strategies that advance PCORI’s National Priorities for Health.”

 

The largest funding announcement, the Phased Large Awards for Comparative Effectiveness Research (PLACER) PFA, seeks proposals for bold, innovative, large trials on important decisional dilemmas that begin with an initial feasibility and planning phase ahead of the full study. PCORI requires submissions under this PFA to align with the organization’s National Priorities for Health and encourages alignment with Topic Themes approved by the PCORI Board of Governors and which reflect health issues facing large numbers of Americans, including reducing maternal morbidity and mortality and improving care for individuals with intellectual or developmental disabilities. PCORI is offering up to $200 million total through this PFA.   

 

The second-largest funding announcement, the Broad Pragmatic Studies PFA, similarly seeks proposals for CER studies aligned with PCORI’s National Priorities for Health and that also may address one or more of the approved Topic Themes. In addition, PCORI welcomes submissions in a new category within this standing funding opportunity explicitly inviting proposals for projects that will use PCORnet®, the National Patient-Centered Clinical Research Network funded by PCORI, to conduct studies that are national in scale. PCORI is offering up to $162 million total through this PFA.  

 

The first of two Targeted PFAs seeks proposals for CER studies focused on comparing pharmacologic and/or evidence-based nonpharmacologic treatments for the prevention of migraine. The second targeted PFA seeks proposals on health system strategies to address disparities in hypertension management and control. PCORI is offering up to $90 million through these two PFAs.   

 

PCORI encourages investigators who respond to any of these funding opportunities to identify and collect data on the full range of patient-centered and clinical outcomes relevant to patients, caregivers and the broader health and health care community. In addition to health outcomes and clinical effectiveness, relevant outcomes could include, as appropriate, potential burdens and economic impacts. 

 

Another PFA seeks proposals for studies to improve methodologies for conducting patient-centered CER to enhance scientific rigor across this field of research. PCORI is offering up to $12 million through this PFA.  

   

In addition to funding research, PCORI also supports initiatives to accelerate the uptake of useful CER evidence into practice to improve health care and health outcomes. Three implementation PFAs seek proposals for projects to support the uptake of PCORI-funded research results and advance approaches to effective shared decision making in practice settings.  

 

An additional PFA seeks proposals for studies focused on strengthening and enhancing the science of engagement in health research. This groundbreaking initiative is a natural evolution of PCORI’s leadership in funding patient-centered research and supports more strategic approaches to promoting meaningful involvement and partnership of stakeholders throughout the research process. PCORI is offering up to $4.5 million through this PFA.  

 

“Guided by our National Priorities for Health, PCORI’s latest funding opportunities build on the organization’s success in funding research that that provides patients and other health care decision  makers with the information they need to make better-informed choices among their health care options,” said Harv Feldman, M.D., MSCE, PCORI’s deputy executive director for patient-centered research programs. “These opportunities also reflect PCORI’s commitment to continuously improving the quality of research methods, stakeholder engagement in research, and enabling the generation of sound evidence to be adopted into clinical practice where it benefits patients, clinicians and health systems.”  

 

To date, PCORI has invested approximately $4 billion to fund patient-centered CER and other research-related projects. Details about the most recent funding announcements are on PCORI’s website.  

  

About PCORI  

The Patient-Centered Outcomes Research Institute (PCORI) is an independent nonprofit organization authorized by Congress in 2010. Its mission is to fund research that will provide patients, their caregivers and clinicians with the evidence-based information needed to make better-informed health care decisions. PCORI is committed to continuously seeking input from a broad range of stakeholders to guide its work.  

  

Media Contacts  

Sofia Kosmetatos  

[email protected]  

202-738-3335  

  

 



Share12Tweet8Share2ShareShareShare2

Related Posts

Chemical Dimerization Inhibits GSDMD-Driven Pyroptosis

October 13, 2025

Psychedelic 5-HT2A Activation Changes Brain Blood Flow

October 13, 2025

Cost-Effectiveness of New TB Diagnosis Methods in Uganda

October 13, 2025

Optimizing Omadacycline Dosing for NTM-PD Treatment

October 13, 2025

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1230 shares
    Share 491 Tweet 307
  • New Study Reveals the Science Behind Exercise and Weight Loss

    103 shares
    Share 41 Tweet 26
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    100 shares
    Share 40 Tweet 25
  • Revolutionizing Optimization: Deep Learning for Complex Systems

    91 shares
    Share 36 Tweet 23

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Efficient Matrix Solving with Resistive RAM Technology

Chemical Dimerization Inhibits GSDMD-Driven Pyroptosis

Dana-Farber Leads Phase 3 Trials for Breast, Lung, and Bladder Cancer Unveiled at ESMO Congress 2025

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 64 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.